Analysts’ ratings for Harmony Biosciences Hldgs (NASDAQ: HRMY) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
Latest Ratings for HRMY
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 2021 | Oppenheimer | Initiates Coverage On | Outperform | |
| Nov 2021 | Raymond James | Initiates Coverage On | Outperform | |
| Sep 2021 | Needham | Initiates Coverage On | Buy |
